Oncology Institute, Inc. (TOIIW) SEC Filings — 2024
16 SEC filings for Oncology Institute, Inc. (TOIIW) in 2024.
Filings
- Oncology Institute Faces Nasdaq Delisting Concern — 8-K · Dec 19, 2024
- Oncology Institute Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
- Oncology Institute Appoints New CMO, Adds Directors — 8-K · Nov 12, 2024
- Oncology Institute Files 8-K: Board Changes & Executive Comp — 8-K · Sep 23, 2024
- Havencrest Healthcare Partners Amends Oncology Institute Stake — SC 13D/A · Aug 20, 2024
- Oncology Institute, Inc. Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Oncology Institute Faces Delisting Concerns — 8-K · Jun 21, 2024
- Oncology Institute Schedules Shareholder Vote — 8-K · Jun 13, 2024
- Oncology Institute Files 2023 Annual Report Amendment — 10-K/A · May 22, 2024
- Oncology Institute, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Oncology Institute, Inc. Announces Annual Meeting of Stockholders on June 13, 2024 — DEF 14A · May 2, 2024
- Oncology Institute, Inc. Files 10-K/A Amendment — 10-K/A · Apr 22, 2024
- Oncology Institute, Inc. Formerly DFP Healthcare Acquisitions Corp. — 8-K · Apr 3, 2024
- Oncology Institute, Inc. Files 2023 Annual Report (10-K) — 10-K · Mar 28, 2024
- Oncology Institute Files 8-K on Financials — 8-K · Mar 27, 2024
- Havencrest Healthcare Amends Oncology Institute Stake — SC 13D/A · Jan 2, 2024